GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,040
-910 (-5.07%)
May 20, 2026, 3:30 PM KST
Market Cap788.99B -44.2%
Revenue (ttm)81.53B +30.1%
Net Income-11.34B
EPS-274.98
Shares Out43.95M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume253,565
Average Volume299,489
Open17,730
Previous Close17,950
Day's Range16,640 - 17,730
52-Week Range16,570 - 72,700
Beta1.02
RSI21.30
Earnings DateMay 22, 2026

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Industrial - Machinery
Founded 1998
Employees 182
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2025, GemVax&KAEL's revenue was 81.53 billion, an increase of 30.05% compared to the previous year's 62.69 billion. Losses were -11.34 billion, -87.00% less than in 2024.

Financial Statements